Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colonography, Computed Tomographic | 36 | 2020 | 170 | 9.520 |
Why?
|
Colonic Polyps | 20 | 2020 | 554 | 3.220 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 17 | 2014 | 1222 | 2.350 |
Why?
|
Radiographic Image Enhancement | 15 | 2014 | 876 | 1.910 |
Why?
|
Feces | 15 | 2018 | 1495 | 1.830 |
Why?
|
Pattern Recognition, Automated | 12 | 2014 | 997 | 1.510 |
Why?
|
Colon | 9 | 2021 | 1792 | 1.200 |
Why?
|
Liquid Crystals | 5 | 2019 | 22 | 1.050 |
Why?
|
Subtraction Technique | 6 | 2014 | 512 | 0.980 |
Why?
|
Diagnosis, Computer-Assisted | 11 | 2023 | 710 | 0.890 |
Why?
|
Imaging, Three-Dimensional | 16 | 2012 | 4063 | 0.890 |
Why?
|
Cisplatin | 3 | 2017 | 1647 | 0.890 |
Why?
|
Artifacts | 7 | 2014 | 1910 | 0.860 |
Why?
|
Deglutition | 1 | 2023 | 208 | 0.760 |
Why?
|
Cathartics | 6 | 2018 | 127 | 0.730 |
Why?
|
Carcinoma, Hepatocellular | 5 | 2015 | 2299 | 0.720 |
Why?
|
Colorectal Neoplasms | 6 | 2018 | 6901 | 0.650 |
Why?
|
Artificial Intelligence | 9 | 2023 | 2578 | 0.630 |
Why?
|
Sensitivity and Specificity | 25 | 2021 | 14665 | 0.600 |
Why?
|
Tomography, X-Ray Computed | 15 | 2021 | 20555 | 0.580 |
Why?
|
Liver Neoplasms | 5 | 2015 | 4321 | 0.570 |
Why?
|
Ovarian Neoplasms | 7 | 2020 | 4877 | 0.570 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 3 | 2014 | 200 | 0.540 |
Why?
|
Contrast Media | 12 | 2018 | 5310 | 0.540 |
Why?
|
Organoplatinum Compounds | 1 | 2017 | 407 | 0.510 |
Why?
|
Laxatives | 3 | 2012 | 92 | 0.480 |
Why?
|
Abdomen | 1 | 2020 | 1128 | 0.470 |
Why?
|
Matrix Metalloproteinase 7 | 5 | 2007 | 60 | 0.450 |
Why?
|
False Positive Reactions | 10 | 2012 | 956 | 0.440 |
Why?
|
User-Computer Interface | 3 | 2012 | 1399 | 0.430 |
Why?
|
Colonoscopy | 5 | 2020 | 1394 | 0.430 |
Why?
|
Refractometry | 2 | 2014 | 57 | 0.430 |
Why?
|
Pneumothorax | 3 | 2012 | 383 | 0.430 |
Why?
|
Iohexol | 2 | 2013 | 204 | 0.410 |
Why?
|
Air | 1 | 2013 | 186 | 0.410 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2020 | 8997 | 0.410 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2007 | 273 | 0.400 |
Why?
|
Colonic Neoplasms | 6 | 2007 | 2534 | 0.390 |
Why?
|
Electronics, Medical | 1 | 2012 | 72 | 0.390 |
Why?
|
Algorithms | 15 | 2018 | 14025 | 0.390 |
Why?
|
Adenomatous Polyps | 1 | 2012 | 108 | 0.380 |
Why?
|
Reproducibility of Results | 20 | 2023 | 20092 | 0.350 |
Why?
|
Cation Transport Proteins | 1 | 2013 | 326 | 0.350 |
Why?
|
Matrix Metalloproteinase 2 | 5 | 2007 | 459 | 0.350 |
Why?
|
Pinus | 1 | 2009 | 16 | 0.350 |
Why?
|
Diatrizoate Meglumine | 1 | 2009 | 79 | 0.340 |
Why?
|
Barium Sulfate | 1 | 2009 | 180 | 0.320 |
Why?
|
Magnetic Resonance Angiography | 1 | 2015 | 1432 | 0.310 |
Why?
|
Lung | 3 | 2021 | 9994 | 0.310 |
Why?
|
Image Enhancement | 3 | 2009 | 2884 | 0.310 |
Why?
|
Photochemistry | 1 | 2008 | 239 | 0.310 |
Why?
|
Crystallization | 1 | 2008 | 533 | 0.290 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2012 | 474 | 0.290 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2013 | 5297 | 0.290 |
Why?
|
Nonlinear Dynamics | 1 | 2009 | 493 | 0.280 |
Why?
|
Adenoma | 1 | 2016 | 2159 | 0.260 |
Why?
|
Polymers | 2 | 2014 | 1614 | 0.260 |
Why?
|
Phantoms, Imaging | 6 | 2013 | 2524 | 0.260 |
Why?
|
Carcinoma | 1 | 2016 | 2328 | 0.240 |
Why?
|
Liver | 2 | 2020 | 7531 | 0.240 |
Why?
|
Adenocarcinoma, Clear Cell | 4 | 2013 | 217 | 0.240 |
Why?
|
Water | 2 | 2019 | 1410 | 0.240 |
Why?
|
Supine Position | 1 | 2005 | 205 | 0.240 |
Why?
|
Pyrroles | 3 | 2015 | 1126 | 0.230 |
Why?
|
Cystadenocarcinoma, Serous | 4 | 2013 | 478 | 0.230 |
Why?
|
Nanotechnology | 1 | 2010 | 712 | 0.230 |
Why?
|
Humans | 77 | 2023 | 761326 | 0.230 |
Why?
|
Prone Position | 1 | 2005 | 196 | 0.230 |
Why?
|
Antigens, Neoplasm | 2 | 2021 | 1994 | 0.230 |
Why?
|
Cluster Analysis | 3 | 2009 | 2712 | 0.220 |
Why?
|
ROC Curve | 8 | 2019 | 3572 | 0.220 |
Why?
|
Antineoplastic Agents | 5 | 2017 | 13635 | 0.220 |
Why?
|
Gallium | 1 | 2002 | 28 | 0.210 |
Why?
|
Metallothionein | 1 | 2002 | 61 | 0.210 |
Why?
|
Indoles | 3 | 2015 | 1832 | 0.200 |
Why?
|
Middle Aged | 37 | 2021 | 220774 | 0.200 |
Why?
|
Immunoenzyme Techniques | 5 | 2013 | 1704 | 0.200 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2009 | 3356 | 0.190 |
Why?
|
Cadmium | 1 | 2002 | 213 | 0.190 |
Why?
|
Aged | 31 | 2021 | 169179 | 0.190 |
Why?
|
Aged, 80 and over | 23 | 2021 | 58946 | 0.190 |
Why?
|
Endometrial Neoplasms | 5 | 2013 | 1365 | 0.190 |
Why?
|
Sacroiliitis | 1 | 2020 | 10 | 0.180 |
Why?
|
Fluorescent Antibody Technique | 3 | 2021 | 2468 | 0.180 |
Why?
|
Prognosis | 11 | 2021 | 29588 | 0.180 |
Why?
|
Sacroiliac Joint | 1 | 2020 | 57 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 5 | 2020 | 6473 | 0.170 |
Why?
|
Automation | 2 | 2021 | 587 | 0.170 |
Why?
|
Japan | 4 | 2018 | 1372 | 0.170 |
Why?
|
Radiography, Thoracic | 2 | 2004 | 1303 | 0.170 |
Why?
|
Female | 42 | 2021 | 392485 | 0.170 |
Why?
|
Spondylarthritis | 1 | 2020 | 59 | 0.170 |
Why?
|
Staining and Labeling | 2 | 2014 | 1085 | 0.170 |
Why?
|
Hospitals, University | 2 | 2018 | 564 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 5 | 2020 | 36430 | 0.160 |
Why?
|
Mass Screening | 2 | 2006 | 5428 | 0.160 |
Why?
|
Area Under Curve | 1 | 2023 | 1633 | 0.160 |
Why?
|
Fluoroscopy | 1 | 2023 | 947 | 0.160 |
Why?
|
Software | 2 | 2013 | 4439 | 0.160 |
Why?
|
Thorax | 1 | 2021 | 555 | 0.150 |
Why?
|
Nanoparticles | 1 | 2010 | 1955 | 0.150 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2013 | 517 | 0.150 |
Why?
|
Adult | 29 | 2021 | 221122 | 0.150 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2007 | 2019 | 0.150 |
Why?
|
Microtubule-Associated Proteins | 1 | 2003 | 1075 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11735 | 0.140 |
Why?
|
Survival Analysis | 3 | 2021 | 10075 | 0.140 |
Why?
|
Neoplasm Staging | 8 | 2020 | 11098 | 0.140 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15262 | 0.140 |
Why?
|
Immunochemistry | 1 | 2016 | 119 | 0.140 |
Why?
|
Angiogenesis Inhibitors | 3 | 2015 | 2047 | 0.140 |
Why?
|
Fractals | 2 | 2014 | 128 | 0.140 |
Why?
|
Male | 30 | 2021 | 360621 | 0.130 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3460 | 0.130 |
Why?
|
Integrins | 1 | 2021 | 834 | 0.130 |
Why?
|
Liver Circulation | 1 | 2015 | 159 | 0.130 |
Why?
|
Single-Blind Method | 2 | 2009 | 1571 | 0.120 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2017 | 194 | 0.120 |
Why?
|
Kinetics | 2 | 2015 | 6374 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2019 | 13333 | 0.120 |
Why?
|
Membrane Proteins | 1 | 2011 | 7852 | 0.110 |
Why?
|
Retrospective Studies | 14 | 2020 | 80575 | 0.110 |
Why?
|
Quality Control | 3 | 2013 | 835 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3734 | 0.110 |
Why?
|
Disease-Free Survival | 4 | 2017 | 6815 | 0.110 |
Why?
|
Fuzzy Logic | 2 | 2004 | 57 | 0.110 |
Why?
|
Candidemia | 1 | 2014 | 39 | 0.110 |
Why?
|
Heat-Shock Proteins | 2 | 2008 | 796 | 0.110 |
Why?
|
Candida | 1 | 2014 | 173 | 0.110 |
Why?
|
Kidney | 2 | 2009 | 7049 | 0.100 |
Why?
|
Color | 1 | 2014 | 299 | 0.100 |
Why?
|
Pilot Projects | 3 | 2015 | 8632 | 0.100 |
Why?
|
Autoantibodies | 1 | 2021 | 2123 | 0.100 |
Why?
|
Benzimidazoles | 1 | 2017 | 858 | 0.100 |
Why?
|
Maximum Tolerated Dose | 2 | 2017 | 883 | 0.100 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2009 | 2498 | 0.100 |
Why?
|
Reference Standards | 3 | 2013 | 1004 | 0.100 |
Why?
|
Models, Chemical | 1 | 2014 | 611 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2009 | 1405 | 0.100 |
Why?
|
Clostridium Infections | 1 | 2018 | 558 | 0.100 |
Why?
|
Nanopores | 1 | 2011 | 44 | 0.090 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2007 | 4022 | 0.090 |
Why?
|
Candida albicans | 1 | 2014 | 373 | 0.090 |
Why?
|
Hemoglobins | 1 | 2016 | 1524 | 0.090 |
Why?
|
Diagnostic Imaging | 2 | 2023 | 3531 | 0.090 |
Why?
|
Sus scrofa | 1 | 2012 | 428 | 0.090 |
Why?
|
Radiation Dosage | 1 | 2018 | 1958 | 0.090 |
Why?
|
Survival Rate | 3 | 2014 | 12710 | 0.080 |
Why?
|
Cellulose | 1 | 2009 | 118 | 0.080 |
Why?
|
Thoracic Injuries | 1 | 2012 | 288 | 0.080 |
Why?
|
Response Elements | 1 | 2011 | 308 | 0.080 |
Why?
|
Information Storage and Retrieval | 2 | 2005 | 819 | 0.080 |
Why?
|
Biomass | 1 | 2009 | 137 | 0.080 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 587 | 0.080 |
Why?
|
Codon | 1 | 2011 | 602 | 0.080 |
Why?
|
Phase Transition | 1 | 2008 | 71 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1922 | 0.080 |
Why?
|
Temperature | 2 | 2019 | 2229 | 0.080 |
Why?
|
Hydrolysis | 1 | 2009 | 665 | 0.080 |
Why?
|
Radiography, Abdominal | 1 | 2012 | 534 | 0.080 |
Why?
|
Neoplasm Invasiveness | 4 | 2005 | 3588 | 0.080 |
Why?
|
Tooth | 1 | 2009 | 210 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2007 | 3489 | 0.080 |
Why?
|
Bacteriophage lambda | 1 | 2008 | 142 | 0.080 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2012 | 589 | 0.070 |
Why?
|
Catalysis | 1 | 2009 | 774 | 0.070 |
Why?
|
Glucose Transporter Type 3 | 1 | 2007 | 16 | 0.070 |
Why?
|
Normal Distribution | 1 | 2008 | 272 | 0.070 |
Why?
|
Calcium-Binding Proteins | 1 | 2012 | 1069 | 0.070 |
Why?
|
X-Rays | 1 | 2008 | 307 | 0.070 |
Why?
|
Lasers | 1 | 2011 | 951 | 0.070 |
Why?
|
Cachexia | 1 | 2009 | 199 | 0.070 |
Why?
|
Mouth | 1 | 2009 | 380 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7439 | 0.070 |
Why?
|
Glucose Transporter Type 4 | 1 | 2007 | 240 | 0.070 |
Why?
|
Glucose Transporter Type 1 | 1 | 2007 | 186 | 0.070 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2007 | 632 | 0.070 |
Why?
|
Iopamidol | 1 | 2007 | 186 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2017 | 5247 | 0.070 |
Why?
|
Adenocarcinoma | 2 | 2007 | 6332 | 0.070 |
Why?
|
Multiple Organ Failure | 1 | 2009 | 386 | 0.070 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 699 | 0.060 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2008 | 398 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2005 | 97 | 0.060 |
Why?
|
Apoptosis | 3 | 2009 | 9474 | 0.060 |
Why?
|
Neurofibromatosis 2 | 1 | 2009 | 385 | 0.060 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6128 | 0.060 |
Why?
|
Lactobacillus | 1 | 2006 | 212 | 0.060 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2005 | 119 | 0.060 |
Why?
|
Cyclooxygenase 2 | 1 | 2007 | 597 | 0.060 |
Why?
|
Polyps | 1 | 2006 | 200 | 0.060 |
Why?
|
Microbial Sensitivity Tests | 3 | 2018 | 1956 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13500 | 0.060 |
Why?
|
Estrogens | 1 | 2011 | 1521 | 0.060 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2004 | 141 | 0.060 |
Why?
|
Neurofibromatosis 1 | 1 | 2009 | 560 | 0.060 |
Why?
|
Neurilemmoma | 1 | 2009 | 525 | 0.060 |
Why?
|
Models, Molecular | 1 | 2014 | 5439 | 0.060 |
Why?
|
Neoplasms, Experimental | 1 | 2009 | 1229 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2012 | 1409 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2020 | 64645 | 0.050 |
Why?
|
Computer Graphics | 1 | 2005 | 340 | 0.050 |
Why?
|
Matrix Metalloproteinases | 1 | 2005 | 392 | 0.050 |
Why?
|
Maltose-Binding Proteins | 1 | 2002 | 62 | 0.050 |
Why?
|
Decision Support Systems, Clinical | 1 | 2012 | 1175 | 0.050 |
Why?
|
Adsorption | 1 | 2002 | 197 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 18401 | 0.050 |
Why?
|
Discriminant Analysis | 1 | 2002 | 222 | 0.050 |
Why?
|
Organ Size | 1 | 2007 | 2252 | 0.050 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2003 | 197 | 0.050 |
Why?
|
Neovascularization, Pathologic | 2 | 2014 | 2644 | 0.050 |
Why?
|
Adolescent | 8 | 2018 | 88305 | 0.050 |
Why?
|
Rectum | 1 | 2006 | 892 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2012 | 2985 | 0.050 |
Why?
|
Cell Line, Tumor | 4 | 2011 | 16966 | 0.050 |
Why?
|
Administration, Oral | 1 | 2009 | 4013 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2008 | 6525 | 0.050 |
Why?
|
False Negative Reactions | 1 | 2002 | 573 | 0.050 |
Why?
|
Chelating Agents | 1 | 2002 | 387 | 0.050 |
Why?
|
Escherichia coli Proteins | 1 | 2008 | 1067 | 0.050 |
Why?
|
Swine | 2 | 2009 | 5915 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2012 | 3448 | 0.050 |
Why?
|
Physicians, Family | 1 | 2003 | 350 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12450 | 0.050 |
Why?
|
Estradiol | 1 | 2007 | 1937 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2011 | 2911 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2006 | 1989 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2007 | 8527 | 0.040 |
Why?
|
Prospective Studies | 2 | 2016 | 54405 | 0.040 |
Why?
|
Regression Analysis | 1 | 2009 | 6341 | 0.040 |
Why?
|
Bacterial Proteins | 2 | 2018 | 3847 | 0.040 |
Why?
|
Gadolinium DTPA | 1 | 2002 | 823 | 0.040 |
Why?
|
Ribotyping | 1 | 2018 | 35 | 0.040 |
Why?
|
Escherichia coli | 2 | 2008 | 4234 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2021 | 878 | 0.040 |
Why?
|
ADP Ribose Transferases | 1 | 2018 | 90 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2004 | 12972 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 59196 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2018 | 465 | 0.040 |
Why?
|
Forecasting | 1 | 2006 | 2928 | 0.040 |
Why?
|
Metronidazole | 1 | 2018 | 232 | 0.030 |
Why?
|
Genes, p53 | 2 | 2011 | 712 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10764 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2004 | 1496 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2005 | 1420 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9275 | 0.030 |
Why?
|
Gastroenterology | 1 | 2003 | 577 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2018 | 468 | 0.030 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2003 | 781 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 2 | 2009 | 282 | 0.030 |
Why?
|
bcl-X Protein | 2 | 2009 | 410 | 0.030 |
Why?
|
Vancomycin | 1 | 2018 | 503 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2003 | 2914 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2021 | 3089 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2012 | 26211 | 0.030 |
Why?
|
Itraconazole | 1 | 2014 | 43 | 0.030 |
Why?
|
Binding Sites | 1 | 2002 | 6052 | 0.030 |
Why?
|
Drug Resistance, Fungal | 1 | 2014 | 75 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3806 | 0.030 |
Why?
|
Low Back Pain | 1 | 2002 | 984 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2009 | 4927 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5078 | 0.030 |
Why?
|
Fluconazole | 1 | 2014 | 157 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4908 | 0.030 |
Why?
|
Perfusion Imaging | 1 | 2014 | 196 | 0.030 |
Why?
|
Patient Compliance | 1 | 2003 | 2690 | 0.030 |
Why?
|
Infant | 2 | 2012 | 36202 | 0.030 |
Why?
|
Cause of Death | 1 | 2003 | 3685 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2014 | 490 | 0.020 |
Why?
|
Animals | 5 | 2012 | 168388 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2014 | 500 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15835 | 0.020 |
Why?
|
Chest Tubes | 1 | 2012 | 152 | 0.020 |
Why?
|
Child, Preschool | 2 | 2012 | 42251 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2002 | 3027 | 0.020 |
Why?
|
Electricity | 1 | 2011 | 181 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2003 | 3611 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2003 | 2210 | 0.020 |
Why?
|
Ameloblasts | 1 | 2009 | 17 | 0.020 |
Why?
|
Anisotropy | 1 | 2014 | 1283 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 39974 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 359 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2011 | 451 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11900 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2002 | 4936 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2009 | 436 | 0.020 |
Why?
|
Proline | 1 | 2011 | 457 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6086 | 0.020 |
Why?
|
Radiology | 1 | 2003 | 2113 | 0.020 |
Why?
|
Antifungal Agents | 1 | 2014 | 752 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2003 | 3161 | 0.020 |
Why?
|
Light | 1 | 2014 | 1351 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6768 | 0.020 |
Why?
|
Chronic Disease | 1 | 2002 | 9319 | 0.020 |
Why?
|
Arginine | 1 | 2011 | 933 | 0.020 |
Why?
|
Estrogen Receptor beta | 1 | 2007 | 168 | 0.020 |
Why?
|
Chromatography | 1 | 2006 | 189 | 0.020 |
Why?
|
United States | 2 | 2007 | 72317 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2009 | 283 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2003 | 4246 | 0.020 |
Why?
|
Drainage | 1 | 2012 | 1156 | 0.020 |
Why?
|
Potassium Chloride | 1 | 2006 | 230 | 0.020 |
Why?
|
Multiple Trauma | 1 | 2009 | 369 | 0.020 |
Why?
|
Child | 2 | 2012 | 80156 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2005 | 72 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10498 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 151 | 0.020 |
Why?
|
Thinness | 1 | 2009 | 490 | 0.020 |
Why?
|
Epithelium | 1 | 2009 | 1603 | 0.020 |
Why?
|
Endometrium | 1 | 2007 | 403 | 0.020 |
Why?
|
Dimerization | 1 | 2006 | 891 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2005 | 222 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2008 | 1494 | 0.010 |
Why?
|
Consensus | 1 | 2013 | 3122 | 0.010 |
Why?
|
Estrogen Receptor alpha | 1 | 2007 | 581 | 0.010 |
Why?
|
Erythropoietin | 1 | 2007 | 719 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22124 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5776 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6966 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2007 | 11070 | 0.010 |
Why?
|
Spleen | 1 | 2009 | 2296 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2208 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4567 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2930 | 0.010 |
Why?
|
Rabbits | 1 | 2009 | 4779 | 0.010 |
Why?
|
Blotting, Western | 1 | 2009 | 5034 | 0.010 |
Why?
|
Education, Medical | 1 | 2013 | 1725 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2007 | 12787 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3905 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 3076 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9333 | 0.010 |
Why?
|
Regeneration | 1 | 2009 | 1511 | 0.010 |
Why?
|
Observer Variation | 1 | 2006 | 2605 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6236 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4286 | 0.010 |
Why?
|
Hot Temperature | 1 | 2006 | 1441 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2009 | 1872 | 0.010 |
Why?
|
Body Composition | 1 | 2009 | 2422 | 0.010 |
Why?
|
Body Weight | 1 | 2009 | 4614 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7582 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 74152 | 0.010 |
Why?
|
Myocardium | 1 | 2009 | 4723 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15599 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2007 | 3666 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17640 | 0.010 |
Why?
|
Cell Movement | 1 | 2005 | 5202 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22154 | 0.010 |
Why?
|
Body Mass Index | 1 | 2009 | 12949 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15499 | 0.000 |
Why?
|
Neoplasms | 1 | 2014 | 22158 | 0.000 |
Why?
|
Mice | 1 | 2009 | 81474 | 0.000 |
Why?
|